免疫系统
自身免疫
生物
炎症
免疫学
自身免疫性疾病
甲状腺炎
FOXP3型
代谢途径
线粒体生物发生
重编程
免疫耐受
细胞生物学
甲状腺
间质细胞
T细胞
癌症研究
免疫
线粒体
调节性T细胞
获得性免疫系统
厌氧糖酵解
糖酵解
作者
Mengli Zhou,Weijie Wu,Yingzhao Liu,S Q Wang,Huiyong Peng
标识
DOI:10.1186/s12964-026-02915-y
摘要
Autoimmune thyroid diseases (AITDs), including Hashimoto's thyroiditis and Graves' disease, arise from thyroid-specific autoimmunity driven by a breakdown of immune tolerance and dysregulated T-cell responses. Within this immune network, imbalance between T helper 17 (Th17) cells and regulatory T (Treg) cells has emerged as a major determinant of persistent inflammation and defective immune restraint. These two subsets are supported by distinct but interconnected metabolic programs. Th17 cells preferentially engage glycolytic and anabolic pathways to sustain inflammatory activity, whereas Treg cells rely more strongly on oxidative metabolism and mitochondrial fitness to preserve lineage stability and suppressive function. In AITDs, these intracellular programs are further reshaped by disease-associated microenvironmental cues, including excess iodine, oxidative stress, lactate accumulation, inflammatory cytokines, and tissue-derived stromal signals. This review summarizes how glucose, lipid, mitochondrial, and amino acid metabolism collectively regulate Th17 and Treg differentiation and function. We further examine how these pathways are altered in AITDs and distorted in thyroid and orbital tissues to amplify immune disequilibrium. Finally, we discuss emerging therapeutic strategies aimed at targeting immune metabolic circuits to restore immune homeostasis.
科研通智能强力驱动
Strongly Powered by AbleSci AI